XML 13 R4.htm IDEA: XBRL DOCUMENT v2.3.0.15
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
9 Months Ended
Oct. 01, 2011
Oct. 02, 2010
Operating activities  
Net income$ 4,780,001$ 2,572,034
Adjustments to reconcile net income to net cash (used in) provided by continuing operating activities:  
Depreciation expense2,289,7892,004,721
Amortization of deferred charges20,6855,340
Deferred income taxes62,072(130,545)
Provision for losses on accounts receivable246,293114,754
Provision for losses on inventory1,259,00050,502
Gain on sale of property, plant and equipment(37,025)(46,223)
Cash value of life insurance(54,001)(66,163)
Environmental reserves(202,667)(169,392)
Issuance of treasury stock for director fees78,70467,478
Employee stock option and stock grant compensation199,866132,331
Changes in operating assets and liabilities:  
Accounts receivable(8,884,756)(8,266,279)
Inventories(11,706,393)(11,116,849)
Other assets and liabilities(112,967)453,716
Accounts payable3,436,697710,715
Accrued expenses1,875,9917,262,451
Income taxes payable(154,970)(1,751,220)
Net cash used in operating activities(6,903,681)(8,172,629)
Investing activities  
Purchases of property, plant and equipment(1,985,046)(4,782,486)
Proceeds from sale of property, plant and equipment49,30156,832
Net cash used in investing activities(1,935,745)(4,725,654)
Financing activities  
Net borrowings from long-term debt8,688,1801,772,568
Dividends paid0(1,581,084)
Proceeds from exercised stock options161,90339,066
Net cash provided by (used in) financing activities8,850,083230,550
Increase (decrease) in cash and cash equivalents10,657(12,667,733)
Cash and cash equivalents at beginning of period108,90214,096,557
Cash and cash equivalents at end of period$ 119,559$ 1,428,824